#1 Stock for 2021. The Upcoming Shroom Boom Could Catapult This Psychedelics Company Out of The Galaxy

[Image]( The Upcoming Shroom Boom Could Catapult This Psychedelics Company Out of the Galaxy Greetings Fellow Investor, As fast as the cannabis market exploded from zero to $US24 billion, the psychedelic drug market could go even higher, and more importantly… even faster! That’s because researched psychedelic drugs like psilocybin (aka magic mushrooms), MDMA and ketamine could completely revolutionize mental healthcare as we know it. It’s the biggest mental health breakthrough in 50 years, and will change the lives of countless millions of patients suffering from anxiety, depression, PTSD and other mental health disorders. The total worldwide addressable mental health sector is pegged at US$70 billion. After decades of research, a growing body of evidence shows that psychedelics have a better ability to improve mental health symptoms than any current treatment. Major studies from Yale, Johns Hopkins, and the US National Institute of Mental Health are giving psychedelic drugs legitimacy, helping to open a path to a brand new multi-billion dollar market. [The World’s Smartest Business People Are Betting on the Enormous Rise in the Psychedelics Space]( Investors like PayPal founder Peter Thiel; GoDaddy founder Bob Parsons; and venture capitalists George Sarlo, Steve Cohen, and Mike Novogratz are all in. They’re putting big money behind companies like Compass Pathways and Mind Medicine that are still in the early stages of drug development, years away from seeing revenue. There are several big heavyweights that are backing this little-known company taking a completely different path to early profits, while at the same time establishing a meaningful scientific foothold in the space. [The Billion-Dollar Backers Behind This Company You Are About to Discover]( Paul Rosen, co-founder of PharmaCan Capital Corp. and its first President and CEO, is betting that the company’s strategy to acquire immediate revenue-generating assets will pay off in a big way. So are other top venture capitalists and market leaders, including Kraig Fox, former managing director at investment firm Guggenheim Partners; philanthropist Garyn Angel; serial entrepreneur and venture capitalist Martin Tobias; and Apollo Neuroscience founder Dave Rabin, MD, PhD. [Immediate Path to Profits]( This company’s strategy is to focus initially on immediate positive revenue derived from legal psychedelics. They will do this by growing a chain of retail level medical clinics offering mental health and wellness treatments with the only psychedelic drug that is fully FDA-approved and has a decades-long history of safe use. Much of the emerging research on the superiority of psychedelic drugs for mental health conditions has been conducted using this one specific drug. Medical scientists from Yale say “this is a game changer,” and a “miracle drug.” The director of the US National Institute of Mental Health says it makes “a life-changing impact.” This company also recently acquired a fully licensed top science lab in Canada with existing blue chip clients already bringing revenue and positive cash flow, and further allowing the development of important Intellectual Property (IP) of psilocybin-related research and ownership surrounding mental health. [To Discover This Trailblazing Psychedelics Stock & My Top 7 Reasons to Consider This Company… Click Here]( I’m in, how about you? Blake Desaulniers, Contributor For Investor News Service P.S. This opportunity is as fresh as it gets. It’s like early 2016 in the cannabis revolution, and you remember how that went: savvy cannabis investors who bought Canopy Growth early realized gains of up to 3,220 %. Now it’s a new revolution. And it could be even bigger. Make sure you don’t miss out. P.P.S. Next to leading Compass Pathways, this company is one of the very rare psychedelics companies with support from big name billion-dollar value creators who are either on the board of directors or serve in an advisory capacity. _________________________ DISCLOSURE: The company discussed in this email is a Blake Desaulniers portfolio holding. Blake Desaulniers has not received any payment for the writing of this email or linked article / report. SPONSORED ARTICLE: Investing in any securities is highly speculative. Please be sure to always do your own due diligence before making any investment decisions. Read our full disclaimer [here]( © 202 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC has not been compensated for this specific email, we do have advertisements in this email that we get paid if you click one of the ads (we have not investigated any of the advertisements). Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. PTE Team 9 Downing street Newark NJ 07105 USA [Unsubscribe]( | [Change Subscriber Options](